<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d441">
    <sentence id="DDI-DrugBank.d441.s0" text="Monoamine Oxidase Inhibition: Linezolid is a reversible, nonselective inhibitor of monoamine oxidase.">
        <entity charOffset="30-38" id="DDI-DrugBank.d441.s0.e0" text="Linezolid" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d441.s1" text="Therefore, linezolid has the potential for interaction with adrenergic and serotonergic agents.">
        <entity charOffset="11-19" id="DDI-DrugBank.d441.s1.e0" text="linezolid" type="drug"/>
        <entity charOffset="60-69" id="DDI-DrugBank.d441.s1.e1" text="adrenergic" type="group"/>
        <entity charOffset="75-93" id="DDI-DrugBank.d441.s1.e2" text="serotonergic agents" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d441.s1.e0" e2="DDI-DrugBank.d441.s1.e1" id="DDI-DrugBank.d441.s1.p0" type="int"/>
        <pair ddi="true" e1="DDI-DrugBank.d441.s1.e0" e2="DDI-DrugBank.d441.s1.e2" id="DDI-DrugBank.d441.s1.p1" type="int"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s1.e1" e2="DDI-DrugBank.d441.s1.e2" id="DDI-DrugBank.d441.s1.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d441.s2" text="Adrenergic Agents:Some individuals receiving ZYVOX may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents, vasopressor or dopaminergic agents.">
        <entity charOffset="0-16" id="DDI-DrugBank.d441.s2.e0" text="Adrenergic Agents" type="group"/>
        <entity charOffset="45-49" id="DDI-DrugBank.d441.s2.e1" text="ZYVOX" type="brand"/>
        <entity charOffset="134-155" id="DDI-DrugBank.d441.s2.e2" text="sympathomimetic agents" type="group"/>
        <entity charOffset="158-168" id="DDI-DrugBank.d441.s2.e3" text="vasopressor" type="group"/>
        <entity charOffset="173-191" id="DDI-DrugBank.d441.s2.e4" text="dopaminergic agents" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s2.e0" e2="DDI-DrugBank.d441.s2.e1" id="DDI-DrugBank.d441.s2.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s2.e0" e2="DDI-DrugBank.d441.s2.e2" id="DDI-DrugBank.d441.s2.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s2.e0" e2="DDI-DrugBank.d441.s2.e3" id="DDI-DrugBank.d441.s2.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s2.e0" e2="DDI-DrugBank.d441.s2.e4" id="DDI-DrugBank.d441.s2.p3"/>
        <pair ddi="true" e1="DDI-DrugBank.d441.s2.e1" e2="DDI-DrugBank.d441.s2.e2" id="DDI-DrugBank.d441.s2.p4" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d441.s2.e1" e2="DDI-DrugBank.d441.s2.e3" id="DDI-DrugBank.d441.s2.p5" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d441.s2.e1" e2="DDI-DrugBank.d441.s2.e4" id="DDI-DrugBank.d441.s2.p6" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s2.e2" e2="DDI-DrugBank.d441.s2.e3" id="DDI-DrugBank.d441.s2.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s2.e2" e2="DDI-DrugBank.d441.s2.e4" id="DDI-DrugBank.d441.s2.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s2.e3" e2="DDI-DrugBank.d441.s2.e4" id="DDI-DrugBank.d441.s2.p9"/>
    </sentence>
    <sentence id="DDI-DrugBank.d441.s3" text="Commonly used drugs such as phenylpropanolamine and pseudoephedrine have been specifically studied.">
        <entity charOffset="28-46" id="DDI-DrugBank.d441.s3.e0" text="phenylpropanolamine" type="drug"/>
        <entity charOffset="52-66" id="DDI-DrugBank.d441.s3.e1" text="pseudoephedrine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s3.e0" e2="DDI-DrugBank.d441.s3.e1" id="DDI-DrugBank.d441.s3.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d441.s4" text="Initial doses of adrenergic agents, such as dopamine or epinephrine, should be reduced and titrated to achieve the desired response.">
        <entity charOffset="17-33" id="DDI-DrugBank.d441.s4.e0" text="adrenergic agents" type="group"/>
        <entity charOffset="44-51" id="DDI-DrugBank.d441.s4.e1" text="dopamine" type="drug"/>
        <entity charOffset="56-66" id="DDI-DrugBank.d441.s4.e2" text="epinephrine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s4.e0" e2="DDI-DrugBank.d441.s4.e1" id="DDI-DrugBank.d441.s4.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s4.e0" e2="DDI-DrugBank.d441.s4.e2" id="DDI-DrugBank.d441.s4.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s4.e1" e2="DDI-DrugBank.d441.s4.e2" id="DDI-DrugBank.d441.s4.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d441.s5" text="Serotonergic Agents: Co-administration of linezolid and serotonergic agents was not associated with serotonin syndrome in Phase 1, 2 or 3 studies.">
        <entity charOffset="0-18" id="DDI-DrugBank.d441.s5.e0" text="Serotonergic Agents" type="group"/>
        <entity charOffset="42-50" id="DDI-DrugBank.d441.s5.e1" text="linezolid" type="drug"/>
        <entity charOffset="56-74" id="DDI-DrugBank.d441.s5.e2" text="serotonergic agents" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s5.e0" e2="DDI-DrugBank.d441.s5.e1" id="DDI-DrugBank.d441.s5.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s5.e0" e2="DDI-DrugBank.d441.s5.e2" id="DDI-DrugBank.d441.s5.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s5.e1" e2="DDI-DrugBank.d441.s5.e2" id="DDI-DrugBank.d441.s5.p2"/>
    <negationtags>Serotonergic Agents: Co-administration of linezolid and serotonergic agents was &lt;scope&gt; &lt;cue&gt; not associated with &lt;/cue&gt; serotonin syndrome in Phase 1, 2 or 3 studies. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d441.s6" text="Spontaneous reports of serotonin syndrome associated with co-administration of ZYVOX and serotonergic agents, including antidepressants such as selective serotonin reuptake inhibitors (SSRIs), have been reported.">
        <entity charOffset="79-83" id="DDI-DrugBank.d441.s6.e0" text="ZYVOX" type="brand"/>
        <entity charOffset="89-107" id="DDI-DrugBank.d441.s6.e1" text="serotonergic agents" type="group"/>
        <entity charOffset="120-134" id="DDI-DrugBank.d441.s6.e2" text="antidepressants" type="group"/>
        <entity charOffset="144-182" id="DDI-DrugBank.d441.s6.e3" text="selective serotonin reuptake inhibitors" type="group"/>
        <entity charOffset="185-189" id="DDI-DrugBank.d441.s6.e4" text="SSRIs" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d441.s6.e0" e2="DDI-DrugBank.d441.s6.e1" id="DDI-DrugBank.d441.s6.p0" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d441.s6.e0" e2="DDI-DrugBank.d441.s6.e2" id="DDI-DrugBank.d441.s6.p1" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d441.s6.e0" e2="DDI-DrugBank.d441.s6.e3" id="DDI-DrugBank.d441.s6.p2" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d441.s6.e0" e2="DDI-DrugBank.d441.s6.e4" id="DDI-DrugBank.d441.s6.p3" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s6.e1" e2="DDI-DrugBank.d441.s6.e2" id="DDI-DrugBank.d441.s6.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s6.e1" e2="DDI-DrugBank.d441.s6.e3" id="DDI-DrugBank.d441.s6.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s6.e1" e2="DDI-DrugBank.d441.s6.e4" id="DDI-DrugBank.d441.s6.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s6.e2" e2="DDI-DrugBank.d441.s6.e3" id="DDI-DrugBank.d441.s6.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s6.e2" e2="DDI-DrugBank.d441.s6.e4" id="DDI-DrugBank.d441.s6.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d441.s6.e3" e2="DDI-DrugBank.d441.s6.e4" id="DDI-DrugBank.d441.s6.p9"/>
    </sentence>
    <sentence id="DDI-DrugBank.d441.s7" text="Patients who are treated with ZYVOX and concomitant serotonergic agents should be closely observed for signs and symptoms of serotonin syndrome (e.g., cognitive dysfunction, hyperpyrexia, hyperreflexia, incoordination).">
        <entity charOffset="30-34" id="DDI-DrugBank.d441.s7.e0" text="ZYVOX" type="brand"/>
        <entity charOffset="52-70" id="DDI-DrugBank.d441.s7.e1" text="serotonergic agents" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d441.s7.e0" e2="DDI-DrugBank.d441.s7.e1" id="DDI-DrugBank.d441.s7.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d441.s8" text="If any signs or symptoms occur physicians should consider discontinuation of either one or both agents (ZYVOX or concomitant serotonergic agents).">
        <entity charOffset="104-108" id="DDI-DrugBank.d441.s8.e0" text="ZYVOX" type="brand"/>
        <entity charOffset="125-143" id="DDI-DrugBank.d441.s8.e1" text="serotonergic agents" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d441.s8.e0" e2="DDI-DrugBank.d441.s8.e1" id="DDI-DrugBank.d441.s8.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d441.s9" text="Drug-Laboratory Test Interactions There are no reported drug-laboratory test interactions."><negationtags>Drug-Laboratory Test Interactions There are &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; reported drug-laboratory test interactions. &lt;/scope&gt;</negationtags></sentence>
</document>